Vibro 4 mg Injection belongs to the class of neuromuscular blocking agents. It is mainly used as an adjuvant to general anaesthesia to aid in endotracheal intubation and to give skeletal muscle relaxation during surgery or mechanical breathing.
Vibro 4 mg Injection contains Vecuronium bromide. It relaxes the muscles by blocking the impulses from the nerves.
Vibro 4 mg Injection will be administered only in a hospital setting by an experienced clinician or an anaesthetist. This medicine could occasionally have undesirable side effects, such as skeletal muscle weakness, prolonged skeletal muscle paralysis, respiration insufficiency or apnea, and bronchospasm/respiratory depression. Your doctor will immediately address these issues if they emerge during your procedure.
Vibro 4 mg Injection is not recommended for patients known to be hypersensitive to it. Vibro 4 mg Injection should be used in pregnant women only if clinically needed, and the benefits outweigh the risks. So, inform your doctor before receiving Vibro 4 mg Injection if you are pregnant or planning for pregnancy. So, tell your doctor about your medical conditions, sensitivities, and prescriptions. Breastfeeding should be stopped for a certain period after Vibro 4 mg Injection is administered, as per the doctor's direction. The safety and effectiveness of Vibro 4 mg Injection in pediatric patients under seven weeks of age have not been established. After receiving, patients should not drive or operate heavy machinery for at least 24 hours.